CytoAgents, Quotient Sciences to take COVID-19 drug candidate GP1681 into human trials

By on    Pharma Industry News  

CytoAgents, Quotient Sciences to take COVID-19 drug candidate GP1681 into human trials

US biotech company CytoAgents has joined forces with CDMO and CRO services provider Quotient Sciences to accelerate the development of its COVID-19 drug candidate GP1681 into human clinical trials for the treatment of cytokine storm. According to the partners, scientific consensus is building that severe illness resulting from COVID-19 and other infectious diseases is triggered by […]

Quotient Sciences opens new $15m facility in Garnet Valley to boost drug development capabilities

By on    Pharma Industry News  

Quotient Sciences opens new $15m facility in Garnet Valley to boost drug development capabilities

Quotient Sciences, a UK-based drug development services provider, has inaugurated a new early phase formulation and manufacturing plant in Garnet Valley, Pennsylvania. The facility, spanning 45,000 square feet and representing a $15 million investment, is set to enhance the company’s capabilities in drug formulation and clinical trial manufacturing. The new Garnet Valley plant will focus […]